Efficacy News and Research

RSS

Face masks worn by TB patients could cut transmission rates to non-infected patients

Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.

18 May 2011

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

Pharma Two B announced today it is planning a Phase II study of its new combination therapy, P2B001, in development as a treatment for the early stages of Parkinson's disease. Assuming regulatory approval and the necessary financing, the company plans to commence the Phase II trial in Q4 2011.

18 May 2011

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Micromet, Inc. today announced that data from a Phase 2 clinical trial of the Company's lead product candidate blinatumomab in patients with minimal residual disease positive acute lymphoblastic leukemia were published in the May 16th on-line edition of the Journal of Clinical Oncology.

18 May 2011

Routine Aedes aegypti mosquito control programs less expensive than ITC to fight dengue

The first-known study comparing costs of routine Aedes aegypti mosquito control programs and insecticide-treated curtains reveals that the cost of RACP is substantially lower than that of ITC implementation for dengue control and prevention.

18 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

$Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery$

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratoconus and ectasia following refractive surgery.

18 May 2011

Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

ERYtech Pharma is pleased to announce it has signed an exclusive long term agreement with Teva for the registration, marketing, distribution and sale of Graspa, the company's lead product, in Israel.

18 May 2011

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anacor Pharmaceuticals announced today that the first patient has been dosed in a Phase 2 trial of AN2728 and AN2898 to determine safety, tolerability and efficacy of the two compounds for the topical treatment of mild-to-moderate atopic dermatitis.

18 May 2011

New avenue for treating breast cancer

Researchers at the CHUM Research Centre and the Peter MacCallum Cancer Centre in Australia have identified a new avenue for treating breast cancer.

17 May 2011

Study: Sleep problems more common among urban minority children than previously thought

Sleep problems among urban minority children, including resistance to going to bed, shortened sleep duration, and daytime sleepiness are much more common than previously thought, according to a study conducted by researchers in New York.

17 May 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

Inhalation of hydrogen can reduce hyperoxic lung injury

Inhaling small amounts of hydrogen in addition to concentrated oxygen may help stem the damage to lung tissue that can occur when critically ill patients are given oxygen for long periods of time, according to a rat model study conducted by researchers in Pittsburgh. The study also found hydrogen initiates activation of heme-oxygenase (HO-1), an enzyme that protects lung cells.

17 May 2011

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.

17 May 2011

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

Quintiles, the world's leading biopharmaceutical services company, and Population Genetics Technologies Ltd., creator of innovative solutions to reduce the costs and complexity of large-scale genomic testing and enable correlations with clinical outcomes, today announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

17 May 2011

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

A miniature, easy-to-carry ventilation system with a simple nasal mask may help patients with chronic obstructive pulmonary disease become more active, according to research conducted at medical centers in California and Utah. The compact design offers an attractive alternative to currently available larger, less comfortableventilators and masks.

17 May 2011

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

AstraZeneca today announced results from a long-term study comparing SYMBICORT Inhalation Aerosol 160/4.5 mcg with budesonide pressurized metered-dose inhaler 160 mcg in self-reported African American patients with moderate to severe persistent asthma.

17 May 2011

Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study

The antibiotic linezolid may be more effective than vancomycin in treating ventilated patients who develop methicillin-resistant Staphylococcus aureus (MRSA) pneumonia as a result of their ventilation, according to a study conducted globally by American and French researchers.

17 May 2011

IsoRay third fiscal quarter sales increase 17%

IsoRay Inc., announced financial results for the third fiscal quarter ended March 31, 2011 underscoring significant improvements in quarterly sales revenue growth both sequentially and in the prior year quarter. Sales increased 17% in the period with the Company posting a 581% gain in gross profit compared to the prior year third quarter.

16 May 2011

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.

16 May 2011

Efficacy News and Research

Face masks worn by TB patients could cut transmission rates to non-infected patients

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Routine Aedes aegypti mosquito control programs less expensive than ITC to fight dengue

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

New avenue for treating breast cancer

Study: Sleep problems more common among urban minority children than previously thought

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

Inhalation of hydrogen can reduce hyperoxic lung injury

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study

IsoRay third fiscal quarter sales increase 17%

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News